ES2051705T3 - Preparados con contenido de acidos grasos insaturados para la sintesis de prostaglandinas e hidroxi-acidos grasos en sistemas biologicos. - Google Patents

Preparados con contenido de acidos grasos insaturados para la sintesis de prostaglandinas e hidroxi-acidos grasos en sistemas biologicos.

Info

Publication number
ES2051705T3
ES2051705T3 ES87106520T ES87106520T ES2051705T3 ES 2051705 T3 ES2051705 T3 ES 2051705T3 ES 87106520 T ES87106520 T ES 87106520T ES 87106520 T ES87106520 T ES 87106520T ES 2051705 T3 ES2051705 T3 ES 2051705T3
Authority
ES
Spain
Prior art keywords
acids
prostaglandins
synthesis
prepared
content
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES87106520T
Other languages
English (en)
Spanish (es)
Inventor
Klaus Ulrich Dr Weithmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Application granted granted Critical
Publication of ES2051705T3 publication Critical patent/ES2051705T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
ES87106520T 1986-05-09 1987-05-06 Preparados con contenido de acidos grasos insaturados para la sintesis de prostaglandinas e hidroxi-acidos grasos en sistemas biologicos. Expired - Lifetime ES2051705T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19863615710 DE3615710A1 (de) 1986-05-09 1986-05-09 Zubereitungen fuer die synthese von prostaglandinen und hydroxyfettsaeuren in biologischen systemen

Publications (1)

Publication Number Publication Date
ES2051705T3 true ES2051705T3 (es) 1994-07-01

Family

ID=6300504

Family Applications (1)

Application Number Title Priority Date Filing Date
ES87106520T Expired - Lifetime ES2051705T3 (es) 1986-05-09 1987-05-06 Preparados con contenido de acidos grasos insaturados para la sintesis de prostaglandinas e hidroxi-acidos grasos en sistemas biologicos.

Country Status (16)

Country Link
US (1) US5043328A (enExample)
EP (1) EP0244832B1 (enExample)
JP (1) JPS62267222A (enExample)
KR (1) KR950008306B1 (enExample)
AT (1) ATE77549T1 (enExample)
AU (1) AU603574B2 (enExample)
CA (1) CA1302266C (enExample)
DE (2) DE3615710A1 (enExample)
DK (1) DK167518B1 (enExample)
ES (1) ES2051705T3 (enExample)
GR (1) GR3005768T3 (enExample)
HU (1) HU201671B (enExample)
IE (1) IE60273B1 (enExample)
IL (1) IL82459A (enExample)
PT (1) PT84841B (enExample)
ZA (1) ZA873299B (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2639828B1 (fr) * 1988-12-01 1993-11-05 Lvmh Recherche Utilisation du kaempferol et de certains de ses derives pour la preparation d'une composition cosmetique ou pharmaceutique
EP0427246B1 (de) * 1989-11-09 1995-08-09 ASTA Medica Aktiengesellschaft Arzneimittel, welche als Wirkstoff Schwefel enthaltende Carbonsäuren enthalten sowie deren Verwendung zur Bekämpfung von Retroviren
ES2033193B1 (es) * 1990-10-30 1994-01-16 Ganadera Union Ind Agro Mezcla grasa para nutricion infantil y de adultos.
US5399584A (en) * 1992-05-05 1995-03-21 The Procter & Gamble Company Use of flavone derivatives for gastroprotection
US5569670A (en) * 1992-06-05 1996-10-29 Asta Medica Aktiengesellschaft Combination medications containing alpha-lipoic acid and related
DE69420124T2 (de) * 1993-01-15 2000-03-02 Abbott Laboratories, Abbott Park Strukturierte lipide
SE507682C2 (sv) * 1996-03-29 1998-07-06 Marcin Krotkiewski Farmaceutisk beredning för behandling av gastrit, refluxesofagit, duodenit, dyspepsi och magsårssjukdom innehållande en blandning av ammoniumvismutcitrat och ett alginat
GB9715444D0 (en) 1997-07-22 1997-09-24 Scotia Holdings Plc Therapeutic and dietary compositions
CA2388754C (en) * 1999-10-13 2010-07-13 Marco A. Chacon Therapeutic intervention to mimic the effect of caloric restriction
MXPA02004413A (es) * 1999-11-02 2002-09-02 Depomed Inc Induccion farmacologica del modo de alimentacion, para la administracion aumentada de drogas al estomago.
US6228367B1 (en) * 1999-12-22 2001-05-08 Renew Life, Inc. Food supplement formulation
CA2304906A1 (en) * 2000-04-07 2001-10-07 1411198 Ontario Limited 13-hode, a regulator of vascular biocompatibility and an inhibitor of cell hyperplasia
US7098352B2 (en) * 2001-11-16 2006-08-29 Virtus Nutrition Llc Calcium salt saponification of polyunsaturated oils
AU2003247685A1 (en) * 2002-07-02 2004-01-23 Galileo Pharmaceuticals, Inc. Compositions and methods for reduction of inflammatory symptoms and/or biomarkers in female subjects
US20050164908A1 (en) * 2004-01-23 2005-07-28 Ginsberg Myron D. Neuroprotective complex for treatment of cerebral ischemia and injury
GB0403247D0 (en) 2004-02-13 2004-03-17 Tillotts Pharma Ag A pharmaceutical composition
EA200602014A1 (ru) * 2004-04-30 2007-08-31 ВИРТУС НЬЮТРИШН ЭлЭлСи Синтез солей одновалентных и двухвалентных металлов полиненасыщенных жирных кислот
WO2006054316A1 (en) * 2004-11-16 2006-05-26 Magene Life Sciences Private Limited Method(s) of preparation, stabilization, composition, and administration of gamma-linolenic acid for brain tumors
US20070082063A1 (en) * 2005-10-11 2007-04-12 Douglas Bibus Risk assessment and correction of membrane damage of the upper GI tract
NZ593186A (en) * 2008-10-31 2013-02-22 Lipid Pharmaceuticals Ehf Fatty acids derived from hydrolysing triglycerides for inducing defecation
EP2595625B1 (en) * 2010-07-22 2016-04-20 Ramot at Tel-Aviv University Ltd. Pharmaceutical composition containing a tryptophan derivative
WO2013087808A1 (en) 2011-12-15 2013-06-20 Merz Pharma Gmbh & Co. Kgaa Pharmaceutical composition comprising a pyrazolopyrimidme and cyclodextrin
KR101991544B1 (ko) * 2012-04-16 2019-06-20 로디아 오퍼레이션스 플루오로중합체 조성물
GB201216385D0 (en) 2012-09-13 2012-10-31 Chrysalis Pharma Ag A pharmaceutical composition
US10143219B2 (en) * 2013-03-06 2018-12-04 Rutgers, The State University Of New Jersey Nutritional supplement/feed formula and methods of use thereof to reduce development of Osteochondrosis Dissecans (OCD) lesions

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE237029C (enExample) *
FR2197605A1 (en) * 1972-09-06 1974-03-29 Williams John Foodstuff or skin nutrient to combat cholesterolaemia - contains arachidonic acid or gamma linolenic acid or esters and salts thereof
JPS537492B2 (enExample) * 1973-02-12 1978-03-18
GB1476624A (en) * 1973-05-30 1977-06-16 Cepbepe Tranquiliser medicaments
DE2813814A1 (de) * 1978-03-31 1979-10-18 Boehringer Mannheim Gmbh Hochwirksame, enteral resorbierbare pharmazeutische praeparate
IE53332B1 (en) * 1980-03-14 1988-10-26 Efamol Ltd Pharmaceutical compositions
JPS5735512A (en) * 1980-06-27 1982-02-26 Nippon Oil & Fats Co Ltd Preventive and remedy for thrombosis
JPS5813541A (ja) * 1981-07-16 1983-01-26 Kureha Chem Ind Co Ltd エイコサペンタエン酸又はドコサヘキサエン酸のシクロデキストリン包接化合物
ATE22532T1 (de) * 1982-03-01 1986-10-15 Efamol Ltd Pharmazeutische zusammensetzung.
FR2522935A1 (fr) * 1982-03-10 1983-09-16 Chevalier Jacques Nouveaux produits a base de lait et de ses derives riches en acides gras polyinsatures et leur procede de preparation
JPS58164508A (ja) * 1982-03-26 1983-09-29 Eisai Co Ltd イソプレニルカルボン酸含有外用組成物
EP0093516B1 (en) * 1982-04-29 1986-10-01 Efamol Limited Pharmaceutical composition
US4668704A (en) * 1982-08-09 1987-05-26 Regents Of The University Of California Method for protecting and healing gastro-duodenal mucosa and the liver of mammals
WO1984002271A1 (en) * 1982-12-09 1984-06-21 Hafsten Raymond J Jr Readily-absorpable fatty acid emulsions
GB8302708D0 (en) * 1983-02-01 1983-03-02 Efamol Ltd Pharmaceutical and dietary composition
GB2140806B (en) * 1983-05-28 1987-10-28 Sekimoto Hiroshi Stabilisation of unsaturated fatty acids, fish oils or fish
CA1239587A (en) * 1983-10-24 1988-07-26 David Rubin Combined fatty acid composition for lowering blood cholestrol and triglyceride levels
DE3470277D1 (en) * 1984-01-11 1988-05-11 Von Mletzko Armin Dietetic composition
JPS60184011A (ja) * 1984-03-02 1985-09-19 Itaru Yamamoto 免疫調節剤
IT1176916B (it) * 1984-10-10 1987-08-18 Elvira Pistolesi Composizione farmaceutica o dietetica ad elevata attivita' antitrombotica e antiarteriosclerotica
JPS62187425A (ja) * 1985-10-14 1987-08-15 Michio Nakanishi リノレン酸系化合物含有組成物
DE3719097C1 (de) * 1987-06-06 1988-06-09 Fratzer Uwe Arzneimittel,enthaltend Eicosapentaensaeure und Docosahexaensaeure als ungesaettigte Fettsaeuren sowie Vitamin E

Also Published As

Publication number Publication date
AU7264187A (en) 1987-11-12
HUT44433A (en) 1988-03-28
PT84841A (de) 1987-06-01
IL82459A (en) 1994-07-31
ZA873299B (en) 1987-11-02
ATE77549T1 (de) 1992-07-15
IE60273B1 (en) 1994-06-29
KR950008306B1 (ko) 1995-07-27
PT84841B (pt) 1990-02-08
HU201671B (en) 1990-12-28
DE3779958D1 (de) 1992-07-30
JPS62267222A (ja) 1987-11-19
DK235687D0 (da) 1987-05-08
US5043328A (en) 1991-08-27
AU603574B2 (en) 1990-11-22
IL82459A0 (en) 1987-11-30
DE3615710A1 (de) 1987-11-26
EP0244832A2 (de) 1987-11-11
KR870010867A (ko) 1987-12-18
EP0244832B1 (de) 1992-06-24
CA1302266C (en) 1992-06-02
DK167518B1 (da) 1993-11-15
EP0244832A3 (en) 1989-11-29
DK235687A (da) 1987-11-10
GR3005768T3 (enExample) 1993-06-07
IE871203L (en) 1987-11-09

Similar Documents

Publication Publication Date Title
ES2051705T3 (es) Preparados con contenido de acidos grasos insaturados para la sintesis de prostaglandinas e hidroxi-acidos grasos en sistemas biologicos.
NL191332C (nl) Farmaceutisch preparaat met de ethylester van (all-Z)-5,8,11,14,17-eicosapentaeenzuur.
DOP1979002953A (es) Procedimiento para la purificacion de proteinas y producto obtenido.
ES2022610B3 (es) Compuestos para potenciar la permeabilidad de la piel que utilizan esteres de sacarosa.
NL187352C (nl) Farmaceutisch preparaat, alsmede sulfonzuurester van een 2-oxoalkanol derivaat.
BG44538A3 (bg) Метод за получаване на соли на 5-метокси-2-голяма скоба(4 метокси- 3,5-диметил-2-пиридинил)-метил сулфонил голяма скоба-1н-бензимидазол
MX168468B (es) Procedimiento para la obtencion de (+)1r-trans-2,2 dimetil-3-(2,2-diclorovinil)-ciclopropan-carboxilato de 2,3,5,6-tetrafluorbencilo
IT1217303B (it) Ceppi batterici particolarmente utili per la produzione di vaccini per il trattamenmto di malattie intestinali e simili e metodo di ingegneria gentica per la produzione dei detti vaccini
ES2022454B3 (es) Sistema terapeutico para la liberacion controlada de drogas.
SE7902742L (sv) Disubstituerade 3-cefem-4-karboxylsyraderivat samt forfarande for framstellning derav
FI870808L (fi) 9-alfa, 11-beta-substituerade och 11-beta-substituerade estraner.
ES2025122B3 (es) Procedimiento para obtencion de esteres de acidos alquencarboxilicos.
ES511384A0 (es) "procedimiento para preparar acidos organicos bitioicos".
ES511730A0 (es) "un procedimiento para la preparacion de oxaprocin calcico".
ES2074983T3 (es) Procedimieto para el aislamiento de proteinas de membranas basales a partir de tejidos humanos y animales.
ES2060440T3 (es) Derivados de acidos 1,4-dihidropiridin-dicarboxilicos aril-quinolil substituidos, procedimiento para su fabricacion y su uso en medicamentos.
ES519679A0 (es) Procedimiento para la preparacion de acidos fenilamino-oxo-aceticos y sus esteres.
AR231529A1 (es) Procedimiento para la preparacion de es-ll16ft3sz9ls1ltft1cos de acidos 3-cloro-estiril-2,2-dimetil-dimetil-ciclo propano carboxilicos
ES550932A0 (es) Procedimiento para la determinacion cinetica de la actividad del sistema de complemento de sangre de ser humano o de animal mamifero.
ES2020562B3 (es) Metodo para regular la reproduccion animal.
ES516399A0 (es) "procedimiento para la fabricacion de productos farmaceuticos directamente absorbidos por el intestino delgado".
ES523258A0 (es) Procedimiento perfeccionado para la carbonilacion de olefinas y esteres organicos.
DE3685222D1 (de) Galleersetzende, die fettverdauung foerdernde arzneimittelpraeparate und verfahren zu ihrer herstellung.
IT7826606A0 (it) Impianto per la sterilizzazione di farine animali e simili.
MX6705E (es) Proceso mejorado para la preparacion de suplementos alimenticios medicinales para animales

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 244832

Country of ref document: ES